Publications by authors named "Ken Aldape"

55Publications

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics.

Neuro Oncol 2017 05;19(5):614-624

Division of Neuro-Oncology, Department of Neurological Surgery, University of California San Francisco,San Francisco, California

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now277DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464438PMC
May 2017

Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.

J Neurooncol 2016 08 7;129(1):147-54. Epub 2016 Jun 7.

Division of Neuro-Oncology, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Unit 431, Houston, TX, 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2157-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021066PMC
August 2016

Comparison of next-generation sequencing mutation profiling with BRAF and IDH1 mutation-specific immunohistochemistry.

Am J Surg Pathol 2015 Apr;39(4):454-61

Departments of *Hematopathology †Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000325DOI Listing
April 2015

Glioma.

Nat Rev Dis Primers 2015 07 16;1:15017. Epub 2015 Jul 16.

Department of Neuropathology, Heinrich Heine University Düsseldorf, and German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Heidelberg, partner site Essen/Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2015.17DOI Listing
July 2015

Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.

Neuro Oncol 2013 Jul 15;15(7):829-39. Epub 2013 Mar 15.

Cancer Research Institute of Medical Science, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688008PMC
July 2013

The use of global profiling in biomarker development for gliomas.

Brain Pathol 2011 Jan;21(1):88-95

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Tex, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1750-3639.2010.00456.xDOI Listing
January 2011

Beyond grade: molecular pathology of malignant gliomas.

Semin Radiat Oncol 2009 Jul;19(3):142-9

Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S105342960900018
Publisher Site
http://dx.doi.org/10.1016/j.semradonc.2009.02.001DOI Listing
July 2009

Twenty-year survival in glioblastoma: a case report and molecular profile.

Int J Radiat Oncol Biol Phys 2009 Nov 26;75(4):1162-5. Epub 2009 Mar 26.

Minneapolis Radiation Oncology, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.12.054DOI Listing
November 2009

Molecular predictors in glioblastoma: toward personalized therapy.

Arch Neurol 2008 Jul;65(7):877-83

Department of Neuro-oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 431, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneur.65.7.877DOI Listing
July 2008

Brain tumor stem cells.

Curr Probl Cancer 2008 May-Jun;32(3):124-42

Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.currproblcancer.2008.02.004DOI Listing
July 2008

Prognostic and predictive markers in glioma and other neuroepithelial tumors.

Curr Probl Cancer 2008 May-Jun;32(3):97-123

Baylor College of Medicine/UT-MD Anderson Cancer Center program in Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.currproblcancer.2008.02.003DOI Listing
July 2008

Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402.

Brain Pathol 2008 Jul 26;18(3):360-9. Epub 2008 Mar 26.

Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1750-3639.2008.00129.xDOI Listing
July 2008

Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma.

Proc Natl Acad Sci U S A 2007 Feb 20;104(9):3466-71. Epub 2007 Feb 20.

Department of Tumor Biology and Angiogenesis, Molecular Biology, Biostatistics, and Pathology, Genentech, Inc., South San Francisco, CA 94080, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0611271104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1802005PMC
February 2007

Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms.

Clin Cancer Res 2006 Aug;12(15):4738-46

Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, 02114, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-06-0596DOI Listing
August 2006

Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.

BMC Cancer 2006 Apr 19;6:97. Epub 2006 Apr 19.

Department of Neurological Surgery, Brain Tumor Research Center, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-6-97DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479358PMC
April 2006

Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells.

J Neurooncol 2005 Aug;74(1):31-40

California Pacific Medical Center Research Institute, 475 Brannan St., Suite 220, San Francisco, CA 94107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-004-5950-2DOI Listing
August 2005

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.

Proc Natl Acad Sci U S A 2005 Apr 12;102(16):5814-9. Epub 2005 Apr 12.

Preuss Laboratory for Molecular Neuro-oncology and Department of Neurological Surgery, University of California-San Francisco, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0402870102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC556127PMC
April 2005

Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro.

J Exp Ther Oncol 2004 Jul;4(2):137-43

California Pacific Medical Center Research Institute, California Pacific Medical Center Research Institute, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
July 2004

In vitro test of external Qigong.

BMC Complement Altern Med 2004 Mar 15;4. Epub 2004 Mar 15.

Research Institute, California Pacific Medical Center, San Francisco 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6882-4-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC387832PMC
March 2004

Repeated operations for infiltrative low-grade gliomas without intervening therapy.

J Neurosurg 2003 Jun;98(6):1165-9

Department of Neurological Surgery, University of California at San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/jns.2003.98.6.1165DOI Listing
June 2003

Genetic determinants of malignancy in a mouse model for oligodendroglioma.

Cancer Res 2003 Apr;63(7):1589-95

Department of Neurology, University of California, San Francisco, California 94143-0663, USA.

View Article

Download full-text PDF

Source
April 2003

Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.

Cancer Res 2002 Nov;62(21):6205-10

Department of Neurological Surgery, University of California, San Francisco 94143, USA.

View Article

Download full-text PDF

Source
November 2002

Hemorrhage and VEGF expression in a case of primary CNS lymphoma.

J Neurooncol 2002 May;58(1):53-6

Division of Hematology/Oncology, University of California, San Francisco 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1015887312455DOI Listing
May 2002

Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status.

J Neuropathol Exp Neurol 2002 Apr;61(4):307-20

Department of Pediatrics, St Christopher's Hospital for Children, Philadelhpia, PA 19134, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnen/61.4.307DOI Listing
April 2002

Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.

Clin Cancer Res 2002 Jan;8(1):180-7

Department of Pathology, University of California, San Francisco, San Francisco, California 94143, USA.

View Article

Download full-text PDF

Source
January 2002